<!DOCTYPE html>



<html lang="en">



	<meta charset="UTF-8">

	<meta name="viewport" content="width=device-width, initial-scale=1.0">

	<style>


    .node {

        stroke: #fff;

        stroke-width: 2px;

    }

    

    .link {

        stroke: #777;

        stroke-width: 2px;

    }



</style>

<body>

<a href="https://riskrunners.com">Home</a><br>




<a href="#risk_factors">Jump to Risk Factors</a><br>



<a href="#industry">Jump to Industries</a><br>


<a href="#exposure">Jump to Exposures</a><br>


<a href="#event_code">Jump to Event Codes</a><br>


<a href="#wiki">Jump to Wiki Summary</a><br><br>


    <script src="https://d3js.org/d3.v3.min.js"></script>

    <script>


// set a width and height for our SVG

var width = 3000,


    height = 3000;

    
// setup links

var links =     [
{source: "START_HERE", target: "54: financial condition", fill: "#967117"},
{source: "54: financial condition", target: "54: operations could", fill: "#967117"},
{source: "54: operations could", target: "54: materially", fill: "#967117"},
{source: "54: materially", target: "54: adversely affected by", fill: "#967117"},
{source: "54: financial condition", target: "55: Additional ", fill: "#e4717a"},
{source: "55: Additional ", target: "55: uncertainties", fill: "#e4717a"},
{source: "55: uncertainties", target: "55: predicted may also harm", fill: "#e4717a"},
{source: "55: predicted may also harm", target: "55: operations", fill: "#e4717a"},
{source: "55: operations", target: "55: adversely affect us", fill: "#e4717a"},
{source: "55: Additional ", target: "65: raw materials", fill: "#004b49"},
{source: "65: raw materials", target: "65: sufficient quantities", fill: "#004b49"},
{source: "65: sufficient quantities", target: "65: manufacture", fill: "#004b49"},
{source: "65: raw materials", target: "67: PAGE ", fill: "#008b8b"},
{source: "67: PAGE ", target: "67: customer relationships", fill: "#008b8b"},
{source: "67: customer relationships", target: "67: shortterm purchase commitments", fill: "#008b8b"},
{source: "67: shortterm purchase commitments", target: "67: customers may unilaterally reduce", fill: "#008b8b"},
{source: "67: PAGE ", target: "79: technical knowledge which although", fill: "#7fff00"},
{source: "79: technical knowledge which although", target: "79: nonpatentable", fill: "#7fff00"},
{source: "79: nonpatentable", target: "79: significant", fill: "#7fff00"},
{source: "79: significant", target: "79: enabling us", fill: "#7fff00"},
{source: "79: technical knowledge which although", target: "80: proprietary", fill: "#a020f0"},
{source: "80: proprietary", target: "80: difficult", fill: "#a020f0"},
{source: "80: proprietary", target: "86: new products", fill: "#2a8000"},
{source: "86: new products", target: "86: services may", fill: "#2a8000"},
{source: "86: services may", target: "86: additional risks", fill: "#2a8000"},
{source: "86: new products", target: "91: factors such as compliance with regulations", fill: "#997a8d"},
{source: "91: factors such as compliance with regulations", target: "91: competitive alternatives", fill: "#997a8d"},
{source: "91: competitive alternatives", target: "91: market preferences may", fill: "#997a8d"},
{source: "91: market preferences may", target: "91: also impact", fill: "#997a8d"},
{source: "91: also impact", target: "91: successful implementation", fill: "#997a8d"},
{source: "91: factors such as compliance with regulations", target: "94: competitors", fill: "#2f847c"},
{source: "94: competitors", target: "94: significantly greater resources than", fill: "#2f847c"},
{source: "94: significantly greater resources than", target: "94: difficult", fill: "#2f847c"},
{source: "94: difficult", target: "94: compete against them", fill: "#2f847c"},
{source: "94: competitors", target: "103: numerous governmental regulations", fill: "#355e3b"},
{source: "103: numerous governmental regulations", target: "103: products thirdparty", fill: "#355e3b"},
{source: "103: products thirdparty", target: "103: reimbursement", fill: "#355e3b"},
{source: "103: reimbursement", target: "103: Medicare or Medicaid", fill: "#355e3b"},
{source: "103: numerous governmental regulations", target: "START_HERE", fill: "#355e3b"}]; 
    // create empty nodes array
    var nodes = {};
	var colorFill = [];
	
    // compute nodes from links data
    links.forEach(function(link) {
        link.source = nodes[link.source] ||
            (nodes[link.source] = {name: link.source});
        link.target = nodes[link.target] ||
            (nodes[link.target] = {name: link.target});
		colorFill.push({name: link.source.name, fill: link.fill });
		colorFill.push({name: link.target.name, fill: link.fill });
    });
	
	console.log(colorFill);


    // add a SVG to the body for our viz
    var svg=d3.select('body').append('svg')
        .attr("viewBox", "0 0 " + width + " " + height );

    // use the force
    var force = d3.layout.force()
		.charge(-5000)
		.gravity(0.3)
        .size([width, height])
        .nodes(d3.values(nodes))
        .links(links)
        .on("tick", tick)
        .linkDistance(200)
        .start();

    // add links
    var link = svg.selectAll('.link')
        .data(links)
        .enter().append('line')
        .attr('class', 'link'); 

    // add nodes
    var node = svg.selectAll('.node')
        .data(force.nodes())
        .enter().append('circle')
        .attr('class', 'node')
        .attr('r', width * 0.0035)
		.style("fill", function(d) {
									for (var i = 0; i < colorFill.length; i++) {
										//console.log(d.name);
										if(colorFill[i].name == d.name){
											console.log(colorFill[i].fill);
											return colorFill[i].fill;
										}
									} return "#555";
									
									});
	var label = svg.selectAll(null)
		.data(force.nodes())
		.enter()
		.append("text")
		.text(function (d) { return d.name; })
		.style("text-anchor", "middle")
		.style("fill", "#555")
		.style("font-family", "Arial")
		.style("font-size", 34);


    // what to do 
    function tick(e) {
        
        node.attr('cx', function(d) { return d.x = Math.max(6, Math.min(width - 6, d.x)); })
            .attr('cy', function(d) { return d.y = Math.max(6, Math.min(height - 6, d.y)); })
            .call(force.drag);
            
        link.attr('x1', function(d) { return d.source.x; })
            .attr('y1', function(d) { return d.source.y; })
            .attr('x2', function(d) { return d.target.x; })
            .attr('y2', function(d) { return d.target.y; });
		
		label.attr("x", function(d){ return d.x; })
             .attr("y", function (d) {return d.y - 10; });
        
    }
    
</script><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='industry'>Industries</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Health Care Distribution and Services</td>
    </tr>
    <tr>
      <td>Health Care Facilities</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='exposure'>Exposures</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Economic</td>
    </tr>
    <tr>
      <td>Military</td>
    </tr>
    <tr>
      <td>Intelligence</td>
    </tr>
    <tr>
      <td>Express intent</td>
    </tr>
    <tr>
      <td>Judicial</td>
    </tr>
    <tr>
      <td>Regime</td>
    </tr>
    <tr>
      <td>Leadership</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='event_code'>Event Codes</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Accident</td>
    </tr>
    <tr>
      <td>Solicit support</td>
    </tr>
    <tr>
      <td>Yield to order</td>
    </tr>
    <tr>
      <td>Human death</td>
    </tr>
    <tr>
      <td>Travel to meet</td>
    </tr>
    <tr>
      <td>Demand</td>
    </tr>
    <tr>
      <td>Warn</td>
    </tr>
    <tr>
      <td>Psychological state</td>
    </tr>
    <tr>
      <td>Sports contest</td>
    </tr>
    <tr>
      <td>Propose</td>
    </tr>
    <tr>
      <td>Vote</td>
    </tr>
    <tr>
      <td>Force</td>
    </tr>
    <tr>
      <td>Release or return</td>
    </tr>
    <tr>
      <td>Yield</td>
    </tr>
    <tr>
      <td>Adjust</td>
    </tr>
    <tr>
      <td>Sanction</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='wiki'>Wiki</th>
      <th>Wiki Summary</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Financial_condition_report">Financial condition report</a></td>
      <td>In accounting, a financial condition report (FCR) is a report on the solvency condition of an insurance company that takes into account both the current financial status, as reflected in the balance sheet, and an assessment of the ability of the company to survive future risk scenarios. Risk assessment in an FCR involves dynamic solvency testing, a type of dynamic financial analysis that simulates management response to risk scenarios, to test whether a company could remain solvent in the face of deteriorating economic conditions or major disasters.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Balance_sheet">Balance sheet</a></td>
      <td>In financial accounting, a balance sheet (also known as statement of financial position or statement of financial condition) is a summary of the financial balances of an individual or organization, whether it be a sole proprietorship, a business partnership, a corporation, private limited company or other organization such as government or not-for-profit entity. Assets, liabilities and ownership equity are listed as of a specific date, such as the end of its financial year.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Financial_ratio">Financial ratio</a></td>
      <td>A financial ratio or accounting ratio is a relative magnitude of two selected numerical values taken from an enterprise's financial statements. Often used in accounting, there are many standard ratios used to try to evaluate the overall financial condition of a corporation or other organization.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Trustmark_(bank)">Trustmark (bank)</a></td>
      <td>Trustmark is a commercial bank and financial services company headquartered in Jackson, Mississippi, United States, with subsidiaries Trustmark National Bank, Trustmark Investment Advisors, and Fisher Brown Bottrell Insurance. The bank's initial predecessor, The Jackson Bank, was chartered by the State of Mississippi in 1889.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Financial_analysis">Financial analysis</a></td>
      <td>Financial analysis (also referred to as financial statement analysis or accounting analysis or Analysis of finance) refers to an assessment of the viability, stability, and profitability of a business, sub-business or project. \nIt is performed by professionals who prepare reports using ratios and other techniques, that make use of information taken from financial statements and other reports.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operation_Mincemeat">Operation Mincemeat</a></td>
      <td>Operation Mincemeat was a successful British deception operation of the Second World War to disguise the 1943 Allied invasion of Sicily. Two members of British intelligence obtained the body of Glyndwr Michael, a tramp who died from eating rat poison, dressed him as an officer of the Royal Marines and placed personal items on him identifying him as the fictitious Captain (Acting Major) William Martin.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operations_management">Operations management</a></td>
      <td>Operations management is an area of management concerned with designing and controlling the process of production and redesigning business operations in the production of goods or services. It involves the responsibility of ensuring that business operations are efficient in terms of using as few resources as needed and effective in meeting customer requirements.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Emergency_operations_center">Emergency operations center</a></td>
      <td>An emergency operations center (EOC) is a central command and control facility responsible for carrying out the principles of emergency preparedness and emergency management, or disaster management functions at a strategic level during an emergency, and ensuring the continuity of operation of a company, political subdivision or other organization.\nAn EOC is responsible for strategic direction and operational decisions and does not normally directly control field assets, instead leaving tactical decisions to lower commands.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Special_operations">Special operations</a></td>
      <td>Special operations (S.O.) are military activities conducted, according to NATO, by "specially designated, organized, selected, trained, and equipped forces using unconventional techniques and modes of employment". Special operations may include reconnaissance, unconventional warfare, and counter-terrorism actions, and are typically conducted by small groups of highly-trained personnel, emphasizing sufficiency, stealth, speed, and tactical coordination, commonly known as "special forces".</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Manufacturing">Manufacturing</a></td>
      <td>Manufacturing is the creation or production of goods with the help of equipment, labor, machines, tools, and chemical or biological processing or formulation. It is the essence of secondary sector of the economy.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Gobelins_Manufactory">Gobelins Manufactory</a></td>
      <td>The Gobelins Manufactory (French: Manufacture des Gobelins) is a historic tapestry factory in Paris, France. It is located at 42 avenue des Gobelins, near Les Gobelins métro station in the 13th arrondissement of Paris.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Build-on-demand">Build-on-demand</a></td>
      <td>Build-on-demand or manufacturing on demand (MOD) refers to a manufacturing process where goods are produced only when or as they are required. This allows scalability and adjustable assemblies depending on the current needs of the part requestor or client.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Design_for_manufacturability">Design for manufacturability</a></td>
      <td>Design for manufacturability (also sometimes known as design for manufacturing or DFM) is the general engineering practice of designing products in such a way that they are easy to manufacture. The concept exists in almost all engineering disciplines, but the implementation differs widely depending on the manufacturing technology.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Polyacrylamide_gel_electrophoresis">Polyacrylamide gel electrophoresis</a></td>
      <td>Polyacrylamide gel electrophoresis (PAGE) is a technique widely used in biochemistry, forensic chemistry, genetics, molecular biology and biotechnology to separate biological macromolecules, usually proteins or nucleic acids, according to their electrophoretic mobility. Electrophoretic mobility is a function of the length, conformation and charge of the molecule.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Significant_figures">Significant figures</a></td>
      <td>Significant figures (also known as the significant digits, precision or resolution) of a number in positional notation are digits in the number that are reliable and necessary to indicate the quantity of something.\nIf a number expressing the result of a measurement (e.g., length, pressure, volume, or mass) has more digits than the number of digits allowed by the measurement resolution, then only as many digits as allowed by the measurement resolution are reliable, and so only these can be significant figures.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/The_Simpsons">The Simpsons</a></td>
      <td>The Simpsons is an American animated sitcom created by Matt Groening for the Fox Broadcasting Company. The series is a satirical depiction of American life, epitomized by the Simpson family, which consists of Homer, Marge, Bart, Lisa, and Maggie.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Healing_Is_Difficult">Healing Is Difficult</a></td>
      <td>Healing Is Difficult is the second studio album by Australian singer and songwriter Sia. It was released in the United Kingdom on 9 July 2001 and in the United States on 28 May 2002.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Difficult_to_Cure">Difficult to Cure</a></td>
      <td>Difficult to Cure is the fifth studio album by the British hard rock band Rainbow, released in 1981. The album marked the further commercialization of the band's sound, with Ritchie Blackmore once describing at the time his appreciation of the band Foreigner.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Difficult_Loves">Difficult Loves</a></td>
      <td>Difficult Loves (Italian: Gli amori difficili) is a 1970 short story collection by Italo Calvino. It concerns love and the difficulty of communication.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/For_Love_or_Money_(2014_film)">For Love or Money (2014 film)</a></td>
      <td>For Love or Money (Chinese: 露水红颜) is a Chinese romance film based on Hong Kong novelist Amy Cheung's 2006 novel of the same name. The film was directed by Gao Xixi and starring Liu Yifei and Rain.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/The_Difficult_Couple">The Difficult Couple</a></td>
      <td>The Difficult Couple (Chinese: 难夫难妻; pinyin: Nànfū Nànqī), also translated as Die for Marriage, is a 1913 Chinese film. It is known for being the earliest Chinese feature film.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/New_product_development">New product development</a></td>
      <td>In business and engineering, new product development (NPD) covers the complete process of bringing a new product to market, renewing an existing product or introducing a product in a new market. A central aspect of NPD is product design, along with various business considerations.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Product_innovation">Product innovation</a></td>
      <td>Product innovation is the creation and subsequent introduction of a good or service that is either new, or an improved version of previous goods or services. This is broader than the normally accepted definition of innovation that includes the invention of new products which, in this context, are still considered innovative.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Competition">Competition</a></td>
      <td>Competition is a rivalry where two or more parties strive for a common goal which cannot be shared: where one's gain is the other's loss (an example of which is a zero-sum game). Competition can arise between entities such as organisms, individuals, economic and social groups, etc.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Competitors_for_the_Crown_of_Scotland">Competitors for the Crown of Scotland</a></td>
      <td>When the crown of Scotland became vacant in September 1290 on the death of the seven-year-old child Queen Margaret, 13 claimants to the throne came forward. Those with the most credible claims were John Balliol, Robert Bruce, John Hastings and Floris V, Count of Holland.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Sport_of_athletics">Sport of athletics</a></td>
      <td>Athletics is a group of sporting events that involves competitive running, jumping, throwing, and walking. The most common types of athletics competitions are track and field, road running, cross country running, and racewalking.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/List_of_Dancing_with_the_Stars_(American_TV_series)_competitors">List of Dancing with the Stars (American TV series) competitors</a></td>
      <td>Dancing with the Stars is an American reality television show in which celebrity contestants and professional dance partners compete to be the best dancers, as determined by the show's judges and public voting. The series first broadcast in 2005, and thirty complete seasons have aired on ABC. During each season, competitors are progressively eliminated on the basis of public voting and scores received from the judges until only a few contestants remain.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Competitor_Group">Competitor Group</a></td>
      <td>Competitor Group, Inc. (CGI) is a privately held, for-profit, sports marketing and management company based in Mira Mesa, San Diego, California.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Round-robin_tournament">Round-robin tournament</a></td>
      <td>A round-robin tournament (or all-play-all tournament) is a competition in which each contestant meets every other participant, usually in turn. A round-robin contrasts with an elimination tournament, in which participants are eliminated after a certain number of losses.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Business_mileage_reimbursement_rate">Business mileage reimbursement rate</a></td>
      <td>The business mileage reimbursement rate is an optional standard mileage rate used in the United States for purposes of computing the allowable business deduction, for Federal income tax purposes under the Internal Revenue Code, at 26 U.S.C. § 162, for the business use of a vehicle. Under the law, the taxpayer for each year is generally entitled to deduct either the actual expense amount, or an amount computed using the standard mileage rate, whichever is greater.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Capitation_(healthcare)">Capitation (healthcare)</a></td>
      <td>Capitation is a payment arrangement for health care service providers. It pays a set amount for each enrolled person assigned to them, per period of time, whether or not that person seeks care.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Diagnosis-related_group">Diagnosis-related group</a></td>
      <td>Diagnosis-related group (DRG) is a system to classify hospital cases into one of originally 467 groups, with the last group (coded as 470 through v24, 999 thereafter) being "Ungroupable". This system of classification was developed as a collaborative project by Robert B Fetter, PhD, of the Yale School of Management, and John D. Thompson, MPH, of the Yale School of Public Health.</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='risk_factors'>Risk Factors</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>ATRION CORP       ITEM 1A  <font color="blue">RISK FACTORS</font></td>
    </tr>
    <tr>
      <td>7  ITEM 1A  <font color="blue">RISK FACTORS</font>    In addition to the other information contained in this Form 10-K, the following  <font color="blue">risk factors should</font> be considered <font color="blue">carefully</font> in evaluating our business</td>
    </tr>
    <tr>
      <td>Our  business, <font color="blue">financial condition</font> or results of <font color="blue"><font color="blue">operations</font> could</font> be <font color="blue">materially</font>  <font color="blue"><font color="blue"><font color="blue"><font color="blue">adversely</font> affect</font>ed</font> by</font> any of these risks</td>
    </tr>
    <tr>
      <td><font color="blue">Additional </font>risks and <font color="blue">uncertainties</font>  that we do not currently know about or that we currently believe are immaterial,  or that we have not predicted, may also harm our business <font color="blue">operations</font> or  <font color="blue"><font color="blue"><font color="blue">adversely</font> affect</font> us</font></td>
    </tr>
    <tr>
      <td>o    Our business is <font color="blue"><font color="blue">dependent</font> on</font> the price and <font color="blue">availability</font> of resins and            our ability to <font color="blue">pass on resin price increases</font> to our customers</td>
    </tr>
    <tr>
      <td>The <font color="blue">principal <font color="blue">raw materials</font></font> that we use in our products are                 polyethylene, polypropylene and <font color="blue">polyvinyl chloride resins</font></td>
    </tr>
    <tr>
      <td><font color="blue">Our                 </font>ability to operate profitably is <font color="blue">dependent</font>, in large part, on the                 market for these resins</td>
    </tr>
    <tr>
      <td>The <font color="blue">resins used by us</font> are <font color="blue">derived from</font>                 petroleum and <font color="blue">natural gas</font>; therefore; prices fluctuate                 <font color="blue"><font color="blue">substantially</font> as</font> a result of changes in petroleum and <font color="blue">natural gas</font>                 prices, demand and the <font color="blue">capacity</font> of the companies that produce                 these products to <font color="blue">meet market</font> needs</td>
    </tr>
    <tr>
      <td><font color="blue">Instability </font>in the world                 markets for petroleum and <font color="blue">natural gas</font> could <font color="blue"><font color="blue">adversely</font> affect</font> the                 prices of our <font color="blue">raw materials</font> and their general <font color="blue">availability</font></td>
    </tr>
    <tr>
      <td>Our ability to maintain <font color="blue">profitability</font> is heavily <font color="blue">dependent</font> upon                 our ability to <font color="blue">pass through</font> to our customers the full amount of                 any increase in raw material costs</td>
    </tr>
    <tr>
      <td>If <font color="blue">resin prices increase</font> and                 we are not able to <font color="blue">fully pass on</font> the increases to our customers,                 our results of <font color="blue">operations</font> and our <font color="blue">financial condition</font> will be                 <font color="blue"><font color="blue"><font color="blue">adversely</font> affect</font>ed</font></td>
    </tr>
    <tr>
      <td>o    The loss of a <font color="blue">key supplier</font> of <font color="blue">raw materials</font> could lead to increased            costs and <font color="blue">lower profit margins</font></td>
    </tr>
    <tr>
      <td>The loss of a <font color="blue">key supplier</font> would force us to <font color="blue">purchase raw</font>                 materials in the open market, which may be <font color="blue">at higher prices</font>,                 until we <font color="blue">could secure</font> another source and <font color="blue">such higher prices may</font>                 not allow us to <font color="blue">remain competitive</font></td>
    </tr>
    <tr>
      <td>If we are unable to obtain                 <font color="blue">raw materials</font> in <font color="blue">sufficient quantities</font>, we may not be able to                 <font color="blue">manufacture</font> our products</td>
    </tr>
    <tr>
      <td>Even if we were able to <font color="blue">replace one</font> of                 our raw material <font color="blue">suppliers through</font> another supply arrangement,                 there is no assurance that the terms that we <font color="blue">enter into with such</font>                 <font color="blue">alternate supplier will</font> be as favorable as the supply                 <font color="blue">arrangements</font> that we currently have</td>
    </tr>
    <tr>
      <td>-7-  <PAGE>           o    A substantial portion of our <font color="blue">customer relationships</font> are open            short-term purchase commitments and, as a result, many of our            <font color="blue">customers may <font color="blue">unilaterally</font> reduce</font> the purchase of our products</td>
    </tr>
    <tr>
      <td>A substantial portion of our <font color="blue">customer relationships</font> are <font color="blue">based on</font>                 open short-term purchase commitments</td>
    </tr>
    <tr>
      <td>As a result, many of our                 <font color="blue">customers may <font color="blue">unilaterally</font> reduce</font> the purchase of our products                 or, in certain cases, terminate existing orders for which we may                 have <font color="blue">incurred <font color="blue">significant</font> production costs</font></td>
    </tr>
    <tr>
      <td>A loss of a major                 customer or a number of our smaller customers could <font color="blue">materially</font>                 <font color="blue"><font color="blue">adversely</font> affect</font> our <font color="blue">operations</font> and <font color="blue">financial condition</font></td>
    </tr>
    <tr>
      <td>o    Product <font color="blue">liability</font> claims could <font color="blue"><font color="blue">adversely</font> affect</font> our financial            condition and results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>We may be subject to product <font color="blue">liability</font> claims involving claims of                 <font color="blue">personal injury</font> or <font color="blue">property damage</font></td>
    </tr>
    <tr>
      <td>Our product <font color="blue">liability</font>                 insurance coverage may not be adequate to cover the cost of                 defense and the <font color="blue">potential award</font> in the event of a claim</td>
    </tr>
    <tr>
      <td>Also, a                 well-publicized actual or perceived problem could <font color="blue">adversely</font>                 affect our reputation and reduce the demand for our products</td>
    </tr>
    <tr>
      <td>o    Our success is <font color="blue"><font color="blue">dependent</font> on</font> our ability to develop patentable            products, to preserve our <font color="blue">trade secrets</font> and operate <font color="blue">without infringing</font>            or violating the <font color="blue"><font color="blue">proprietary</font> rights</font> of <font color="blue">third parties</font></td>
    </tr>
    <tr>
      <td>Others <font color="blue">may challenge</font> the validity of any <font color="blue">patents issued</font> to us,                 and we <font color="blue">could encounter legal</font> and <font color="blue">financial <font color="blue">difficult</font>ies</font> in                 enforcing our <font color="blue">patent rights against infringers</font></td>
    </tr>
    <tr>
      <td>In addition,                 there can be no assurance that other <font color="blue">technologies cannot</font> or will                 not be developed or that <font color="blue">patents will</font> not be obtained by others                 <font color="blue">which would</font> render our <font color="blue">patents less</font> valuable or obsolete</td>
    </tr>
    <tr>
      <td>Although we do not believe that patents are the <font color="blue">sole determinant</font>                 in the <font color="blue">commercial success</font> of our products, the loss of a                 <font color="blue"><font color="blue">significant</font> percentage</font> of our patents or of our patents relating                 to a <font color="blue">specific major product line could</font> have a material adverse                 effect on our business, <font color="blue">financial condition</font> and results of                 <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>We have developed technical knowledge which, although                 non-patentable, we consider to be <font color="blue">significant</font> in <font color="blue">enabling us</font> to                 compete</td>
    </tr>
    <tr>
      <td>However, the <font color="blue">proprietary</font> nature of such knowledge may be                 <font color="blue">difficult</font> to protect</td>
    </tr>
    <tr>
      <td>The medical device industry is <font color="blue">characterized by</font> extensive                 <font color="blue">intellectual property <font color="blue">litigation</font></font>, and companies in the medical                 products industry sometimes use <font color="blue">intellectual property <font color="blue">litigation</font></font>                 to gain a <font color="blue">competitive advantage</font></td>
    </tr>
    <tr>
      <td><font color="blue">Intellectual </font>property                 <font color="blue">litigation</font>, regardless of outcome, is <font color="blue">often complex</font> and                 expensive, and the outcome of this <font color="blue">litigation</font> is <font color="blue">generally</font>                 <font color="blue">difficult</font> to predict</td>
    </tr>
    <tr>
      <td>An <font color="blue">adverse <font color="blue">determination</font></font> in any <font color="blue">such proceeding could</font> subject us                 to <font color="blue">significant</font> liabilities to <font color="blue">third parties</font> or require us to seek                 licenses from <font color="blue">third parties</font> or <font color="blue">pay royalties</font> that may be                 substantial</td>
    </tr>
    <tr>
      <td>Furthermore, there can be no assurance that                 <font color="blue"><font color="blue">necessary licenses</font> would</font> be available to us on satisfactory terms                 or at all</td>
    </tr>
    <tr>
      <td>Accordingly, an <font color="blue">adverse <font color="blue">determination</font></font> in a judicial or                 <font color="blue">administrative proceeding</font> or failure to obtain <font color="blue">necessary licenses</font>                 <font color="blue">could <font color="blue">prevent us from <font color="blue">manufacturing</font></font></font> or <font color="blue">selling certain</font> of our                 products, <font color="blue">which could</font> have a material adverse effect on our                 business, <font color="blue">financial condition</font> and results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>o    New lines of business or <font color="blue">new products</font> and <font color="blue">services may</font> subject us to            <font color="blue">additional risks</font></td>
    </tr>
    <tr>
      <td>From time to time, we may implement new lines of business or                 offer <font color="blue">new products</font> and <font color="blue">services within existing lines</font> of                 business</td>
    </tr>
    <tr>
      <td>There are substantial risks and <font color="blue">uncertainties</font>                 <font color="blue">associated with</font> these efforts, particularly in instances where                 the markets are not fully developed</td>
    </tr>
    <tr>
      <td>In developing and marketing                 new lines of business or <font color="blue">new products</font> and services, we may invest                 <font color="blue">significant</font> time and resources</td>
    </tr>
    <tr>
      <td>Initial timetables for the                 <font color="blue">introduction</font> and <font color="blue">development</font> of new lines of business and new                 products or <font color="blue">services may</font> not be                                            -8-  <PAGE>                     achieved and price and <font color="blue">profitability</font> targets may not prove                 feasible</td>
    </tr>
    <tr>
      <td>External factors, such as compliance with <font color="blue">regulations</font>,                 <font color="blue">competitive alternatives</font>, and shifting market preferences, may                 <font color="blue">also impact</font> the <font color="blue">successful <font color="blue">implementation</font></font> of a new line of                 business or a new product or service</td>
    </tr>
    <tr>
      <td>Furthermore, any new line                 of business or new product or service could have a <font color="blue">significant</font>                 <font color="blue">impact on</font> the <font color="blue">effectiveness</font> of our system of internal controls</td>
    </tr>
    <tr>
      <td>Failure to <font color="blue">successfully</font> manage these risks in the <font color="blue">development</font> and                 <font color="blue">implementation</font> of new lines of business or <font color="blue">new products</font> or                 <font color="blue">services could</font> have a material adverse effect on our business,                 results of <font color="blue">operations</font> and <font color="blue">financial condition</font></td>
    </tr>
    <tr>
      <td>o    Our <font color="blue">competitors</font> have <font color="blue">significant</font>ly greater resources than we do, and            it may be <font color="blue">difficult</font> for us to <font color="blue">compete against them</font></td>
    </tr>
    <tr>
      <td>In many of our markets, we <font color="blue">compete with numerous</font> other companies                 that have <font color="blue">substantially</font> greater <font color="blue">financial resources</font> and engage in                 <font color="blue">substantially</font> more research and <font color="blue">development</font> <font color="blue">activities</font> than we                 do</td>
    </tr>
    <tr>
      <td>Furthermore, <font color="blue">innovations</font> in <font color="blue">surgical techniques</font> or medical                 <font color="blue">practices could</font> have the effect of reducing or <font color="blue">eliminating market</font>                 demand for one or more of our products</td>
    </tr>
    <tr>
      <td>Some of the markets in which we compete are dominated by                 established <font color="blue">manufacture</font>rs that have <font color="blue"><font color="blue">broader product line</font>s</font>,                 greater <font color="blue">distribution</font> capabilities, <font color="blue">substantially</font> larger                 marketing, research and <font color="blue">development</font> staffs and <font color="blue"><font color="blue">facilities</font> than</font> we                 do</td>
    </tr>
    <tr>
      <td>Many of these <font color="blue">competitors</font> offer <font color="blue"><font color="blue">broader product line</font>s</font> within                 the specific product market and in the <font color="blue">general field</font> of medical                 devices and supplies</td>
    </tr>
    <tr>
      <td>Broad <font color="blue">product lines give</font> many of our                 <font color="blue">cardiovascular</font> and fluid delivery <font color="blue">competitors</font> the ability to                 negotiate exclusive, long-term medical device <font color="blue">supply contracts</font>                 and, <font color="blue">consequently</font>, the ability to <font color="blue">offer comprehensive pricing</font> of                 their <font color="blue">competing products</font></td>
    </tr>
    <tr>
      <td>By offering a <font color="blue">broader product line</font> in                 the <font color="blue">general field</font> of <font color="blue">medical devices</font> and supplies, <font color="blue">competitors</font>                 may also have a <font color="blue">significant</font> advantage in <font color="blue">marketing competing</font>                 products to group <font color="blue">purchasing organizations</font></td>
    </tr>
    <tr>
      <td>In addition, our                 <font color="blue">competitors</font> may use price reductions to <font color="blue">preserve market</font> share in                 their <font color="blue">product markets</font></td>
    </tr>
    <tr>
      <td>o    We are subject to substantial <font color="blue"><font color="blue"><font color="blue">government</font>al</font> regulation</font> and our failure            to <font color="blue">comply with</font> applicable <font color="blue"><font color="blue"><font color="blue">government</font>al</font> regulation</font>s could subject us to            <font color="blue">numerous penalties</font>, any of <font color="blue">which could</font> <font color="blue"><font color="blue">adversely</font> affect</font> our business</td>
    </tr>
    <tr>
      <td>We are subject to numerous <font color="blue"><font color="blue"><font color="blue">government</font>al</font> regulation</font>s relating to,                 among other things, our ability to sell our products, third-party                 <font color="blue">reimbursement</font> and fraud and abuse of <font color="blue">Medicare or Medicaid</font></td>
    </tr>
    <tr>
      <td>If we                 do not <font color="blue">comply with</font> applicable <font color="blue"><font color="blue"><font color="blue">government</font>al</font> regulation</font>s,                 <font color="blue"><font color="blue"><font color="blue">government</font>al</font> <font color="blue">authorities</font> could</font> do any of the following:                      o    <font color="blue">impose fines</font> and <font color="blue">penalties on us</font>;                      o    <font color="blue">prevent us from <font color="blue">manufacturing</font></font> our products;                      o    <font color="blue">bring civil</font> or <font color="blue">criminal charges against us</font>;                      o    delay the <font color="blue">introduction</font> of our <font color="blue">new products</font> into the                           market;                      o    recall or seize our products;                      o    disrupt the <font color="blue">manufacture</font> or <font color="blue">distribution</font> of our                           products; or                      o    withdraw or <font color="blue">deny approvals</font> for our products</td>
    </tr>
    <tr>
      <td>Any one of these results could <font color="blue">materially</font> <font color="blue"><font color="blue">adversely</font> affect</font> our                 revenues and <font color="blue">profitability</font> and harm our reputation</td>
    </tr>
    <tr>
      <td>-9-  <PAGE>           o    We will be unable to sell our products if we fail to <font color="blue">comply with</font>            <font color="blue"><font color="blue">manufacturing</font> <font color="blue">regulations</font></font></td>
    </tr>
    <tr>
      <td>To commercially <font color="blue">manufacture</font> our products, we must <font color="blue">comply with</font>                 <font color="blue">government</font> <font color="blue"><font color="blue">manufacturing</font> <font color="blue">regulations</font></font> that <font color="blue">govern design controls</font>,                 <font color="blue">quality systems</font> and <font color="blue">documentation policies</font> and procedures</td>
    </tr>
    <tr>
      <td>The                 FDA and equivalent foreign <font color="blue"><font color="blue">government</font>al</font> <font color="blue">authorities</font> <font color="blue">periodically</font>                 inspect our <font color="blue">manufacturing</font> <font color="blue">facilities</font> and the <font color="blue">manufacturing</font>                 <font color="blue">facilities</font> of our OEM medical device customers</td>
    </tr>
    <tr>
      <td>If we or our <font color="blue">OEM                 </font>medical device <font color="blue">customers fail</font> to <font color="blue">comply with</font> these <font color="blue">manufacturing</font>                 <font color="blue">regulations</font> or fail any FDA <font color="blue">inspections</font> our marketing or                 <font color="blue">distribution</font> of our <font color="blue">products may</font> be prevented or delayed, which                 <font color="blue">would negatively impact</font> our business</td>
    </tr>
    <tr>
      <td>o    Our products are subject to <font color="blue"><font color="blue">product recalls</font> even</font> after receiving            <font color="blue"><font color="blue">regulatory</font> clearance</font> or approval, and any <font color="blue">such recalls would</font>            <font color="blue">negatively affect</font> our <font color="blue">financial performance</font> and <font color="blue">could harm</font> our            reputation</td>
    </tr>
    <tr>
      <td>Any of our <font color="blue">products may</font> be found to have <font color="blue">significant</font> <font color="blue">deficiencies</font>                 or defects in design or <font color="blue">manufacture</font></td>
    </tr>
    <tr>
      <td>The FDA and similar                 <font color="blue"><font color="blue">government</font>al</font> <font color="blue">authorities</font> in other countries have the authority to                 require the recall of any such defective product</td>
    </tr>
    <tr>
      <td><font color="blue">A                 </font><font color="blue">government</font>-mandated or <font color="blue">voluntary recall could</font> occur as a result                 of component failures, <font color="blue">manufacturing</font> errors or <font color="blue">design defects</font></td>
    </tr>
    <tr>
      <td><font color="blue">We                 </font>do not maintain insurance to <font color="blue">cover losses incurred as</font> a result of                 <font color="blue">product recalls</font></td>
    </tr>
    <tr>
      <td>Any <font color="blue">product recall would divert managerial</font> and                 <font color="blue">financial resources</font> and <font color="blue">negatively affect</font> our financial                 performance, and <font color="blue">could harm</font> our <font color="blue">reputation with customers</font> and                 end-users</td>
    </tr>
    <tr>
      <td>o    We may not receive <font color="blue"><font color="blue">regulatory</font> approvals</font> for <font color="blue">new <font color="blue">product candidates</font></font> or            <font color="blue">approvals may</font> be delayed</td>
    </tr>
    <tr>
      <td><font color="blue">Regulation </font>by <font color="blue">government</font> <font color="blue">authorities</font> in the <font color="blue">United States </font>and                 foreign countries is a <font color="blue">significant</font> factor in the <font color="blue">development</font>,                 <font color="blue">manufacture</font> and marketing of our <font color="blue">proposed products</font> and in our                 <font color="blue">ongoing research</font> and product <font color="blue">development</font> <font color="blue">activities</font></td>
    </tr>
    <tr>
      <td>Any failure                 to receive the <font color="blue"><font color="blue">regulatory</font> approvals</font> necessary to <font color="blue">commercialize</font>                 our <font color="blue">product candidates</font>, or the <font color="blue">subsequent withdrawal</font> of any such                 approvals, would harm our business</td>
    </tr>
    <tr>
      <td>The process of obtaining                 these approvals and the <font color="blue">subsequent compliance with federal</font> and                 state statutes and <font color="blue">regulations</font> require spending substantial time                 and <font color="blue">financial resources</font></td>
    </tr>
    <tr>
      <td>If we fail to obtain or maintain, or                 <font color="blue">encounter delays</font> in obtaining or maintaining, <font color="blue">regulatory</font>                 approvals, it could <font color="blue"><font color="blue">adversely</font> affect</font> the marketing of any                 products we develop, our ability to receive <font color="blue">product revenues</font>, and                 our liquidity and <font color="blue">capital resources</font></td>
    </tr>
    <tr>
      <td>o    We <font color="blue">rely on technology</font> to operate our business and any failure of these            systems <font color="blue">could harm</font> our business</td>
    </tr>
    <tr>
      <td>We <font color="blue">rely heavily on communications</font> and information systems to                 conduct our business, <font color="blue">enhance customer service</font> and increase                 <font color="blue">employee productivity</font></td>
    </tr>
    <tr>
      <td>Any failure, interruption or breach in                 security of these systems could result in failures or <font color="blue">disruptions</font>                 in our customer relationship management, general ledger,                 inventory, <font color="blue">manufacturing</font> and other systems</td>
    </tr>
    <tr>
      <td>There is no assurance                 that any such failures, interruptions or <font color="blue"><font color="blue">security breaches</font> will</font>                 not occur or, if they do occur, that they will be <font color="blue">adequately</font>                 <font color="blue">addressed by</font> our policies and procedures that are intended to                 safeguard our systems</td>
    </tr>
    <tr>
      <td>The occurrence of any failures,                 interruptions or <font color="blue">security breaches</font> of our information systems                 could damage our reputation, result in a loss of customer                 business, subject us to additional <font color="blue">regulatory</font> scrutiny, or expose                 us to civil <font color="blue">litigation</font> and possible financial <font color="blue">liability</font>, any of                 <font color="blue">which could</font> have a material adverse effect on our financial                 condition and results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>-10-  <PAGE>           o    We sell many of our products to healthcare providers that rely on            Medicare, Medicaid and private health insurance plans to reimburse the            costs <font color="blue">associated with</font> the procedures performed using our products and            these <font color="blue">third party payors</font> may deny <font color="blue">reimbursement</font> for use of our            products</td>
    </tr>
    <tr>
      <td>We are <font color="blue">dependent</font>, in part, upon the ability of healthcare                 providers to obtain satisfactory <font color="blue">reimbursement</font> from third-party                 payors for <font color="blue">medical procedures</font> in which our products are used</td>
    </tr>
    <tr>
      <td>Third-party payors may deny <font color="blue">reimbursement</font> if they determine that                 a <font color="blue">prescribed product</font> has not received appropriate <font color="blue">regulatory</font>                 <font color="blue">clearances</font> or approvals, is not used in <font color="blue">accordance with</font>                 cost-effective treatment methods as determined by the payor, or                 is experimental, unnecessary or <font color="blue">inappropriate</font></td>
    </tr>
    <tr>
      <td>Failure by                 hospitals and other users of our products to obtain <font color="blue">reimbursement</font>                 from third-party payors, or adverse changes in <font color="blue">government</font> and                 private third-party payors &amp;apos  policies toward <font color="blue">reimbursement</font> for                 <font color="blue">procedures employing</font> our products, could have a material adverse                 effect on the Companyapstas business, <font color="blue">financial condition</font> and results                 of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>Major <font color="blue">third party payors</font> for <font color="blue">medical services</font> in                 the <font color="blue">United States </font>and other <font color="blue">countries continue</font> to work to contain                 <font color="blue">healthcare costs</font></td>
    </tr>
    <tr>
      <td>The <font color="blue">introduction</font> of <font color="blue">cost containment</font>                 incentives, combined with closer scrutiny of healthcare                 <font color="blue">expenditures by both private health insurers</font> and employers, has                 resulted in <font color="blue">increased discounts</font> and <font color="blue">contractual adjustments</font> to                 charges for services performed</td>
    </tr>
    <tr>
      <td>Further <font color="blue">implementation</font> of                 <font color="blue">legislative</font> or <font color="blue">administrative reforms</font> to the <font color="blue">United States </font>or                 <font color="blue">international</font> <font color="blue">reimbursement</font> systems in a manner that                 <font color="blue">significant</font>ly reduces <font color="blue">reimbursement</font> for <font color="blue">procedures using</font> our                 products or <font color="blue">denies coverage</font> for <font color="blue">such procedures would</font> have an                 adverse effect on our business, <font color="blue">financial condition</font> and results                 of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td><font color="blue">Hospitals </font>or physicians may respond to these                 cost-containment pressures by <font color="blue">substituting</font> lower cost products or                 other therapies for our products</td>
    </tr>
    <tr>
      <td>o    We may not be able to attract and retain skilled people                 Our <font color="blue">success depends</font>, in large part, on our ability to attract and                 retain key people</td>
    </tr>
    <tr>
      <td><font color="blue">Competition </font>for the best people in most                 <font color="blue">activities</font> we engage in can be intense and we may not be able to                 hire people or to retain them</td>
    </tr>
    <tr>
      <td>The <font color="blue">unexpected loss</font> of services of                 one or more of our <font color="blue">key personnel could</font> have a material adverse                 <font color="blue">impact on</font> our business because of their skills, knowledge of our                 market, years of industry experience and the <font color="blue">difficult</font>y of                 <font color="blue">promptly finding qualified replacement personnel</font></td>
    </tr>
    <tr>
      <td>o    Severe weather, natural disasters, acts of war or terrorism or other            external events could <font color="blue">significant</font>ly impact our business</td>
    </tr>
    <tr>
      <td>We <font color="blue">currently conduct</font> all our <font color="blue">development</font>, <font color="blue">manufacturing</font> and                 <font color="blue">management at three locations</font></td>
    </tr>
    <tr>
      <td>Severe weather, natural disasters,                 acts of war or terrorism and other <font color="blue">adverse external events at</font> any                 one or more of these <font color="blue">locations could</font> have a <font color="blue">significant</font> <font color="blue">impact on</font>                 our ability to conduct business</td>
    </tr>
    <tr>
      <td>Our <font color="blue">disaster recovery policies</font>                 and <font color="blue">procedures may</font> not be effective and the occurrence of any                 <font color="blue">such event could</font> have a material adverse effect on our business,                 which, in turn, could have a material adverse effect on our                 <font color="blue">financial condition</font> and results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>Stock <font color="blue">price volatility may</font> make it more <font color="blue">difficult</font> for you to sell                 your <font color="blue">common stock</font> when you want and at prices you find                 attractive</td>
    </tr>
    <tr>
      <td>Our stock price can fluctuate <font color="blue">significant</font>ly in                 response to a variety of factors including, among other things:                 o    Actual or anticipated <font color="blue">variations</font> in quarterly results of                      <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>o    <font color="blue">Recommendations </font><font color="blue">by securities analysts</font>                 o    <font color="blue">Operating </font>and stock price performance of other companies                      that investors deem comparable to the Company</td>
    </tr>
    <tr>
      <td>o    <font color="blue">Perceptions </font>in the marketplace regarding the Company and our                      <font color="blue">competitors</font>                 o    New <font color="blue">technology used</font>, or services offered, by <font color="blue">competitors</font></td>
    </tr>
    <tr>
      <td>-11-  <PAGE>                     o    <font color="blue">Significant </font><font color="blue">acquisitions</font> or business combinations, strategic                      partnerships, joint ventures or <font color="blue">capital commitments by</font> or                      involving the Company or our <font color="blue">competitors</font></td>
    </tr>
    <tr>
      <td>o    Failure to integrate <font color="blue">acquisitions</font> or realize anticipated                      benefits from <font color="blue">acquisitions</font>                 o    Changes in <font color="blue">government</font> <font color="blue">regulations</font>                 o    <font color="blue">Geopolitical </font><font color="blue">conditions such as</font> acts or threats of terrorism                      or <font color="blue">military conflicts</font></td>
    </tr>
    <tr>
      <td>General market fluctuations, industry factors and general                 economic and <font color="blue">political conditions</font> and events, such as economic                 slowdowns or recessions, interest rate changes or credit loss                 trends, could also cause our stock price to <font color="blue">decrease regardless</font>                 of operating results</td>
    </tr>
  </tbody>
</table>